US2826532A - Process of stabilizing polyvinyl pyrrolidone-iodine compositions - Google Patents

Process of stabilizing polyvinyl pyrrolidone-iodine compositions Download PDF

Info

Publication number
US2826532A
US2826532A US457777A US45777754A US2826532A US 2826532 A US2826532 A US 2826532A US 457777 A US457777 A US 457777A US 45777754 A US45777754 A US 45777754A US 2826532 A US2826532 A US 2826532A
Authority
US
United States
Prior art keywords
iodine
polyvinyl pyrrolidone
available
composition
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US457777A
Inventor
William A Hosmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GAF Chemicals Corp
Original Assignee
General Aniline and Film Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US282458A external-priority patent/US2706701A/en
Application filed by General Aniline and Film Corp filed Critical General Aniline and Film Corp
Priority to US457777A priority Critical patent/US2826532A/en
Application granted granted Critical
Publication of US2826532A publication Critical patent/US2826532A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/18Iodine; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment
    • C08F8/18Introducing halogen atoms or halogen-containing groups
    • C08F8/20Halogenation
    • C08F8/22Halogenation by reaction with free halogens
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/16Halogen-containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24Acids; Salts thereof
    • C08K3/26Carbonates; Bicarbonates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24Acids; Salts thereof
    • C08K3/26Carbonates; Bicarbonates
    • C08K2003/262Alkali metal carbonates

Definitions

  • This invention relates to a process of stabilizing a dry powdered adduct of iodine and polymeric 1-vinyl-2- pyrrolidone (hereinafter referred to as polyvinyl pyrrolidone) whereby a stable composition is obtained which when dissolved in water will not change its pH and maintain a constant available iodine content.
  • polyvinyl pyrrolidone polymeric 1-vinyl-2- pyrrolidone
  • this novel iodine-polyvinyl pyrrolidone composition may be prepared by adding a solution of iodine, such as Lugols solution or tincture of iodine to an aqueous solution of polyvinyl pyrrolidone followed by dessication in a suitable dryer.
  • iodine such as Lugols solution or tincture of iodine
  • This mixing is effected by grinding the iodine and polyvinyl pyrrolidone in a mortar and pestle or more advantageously in a suitable mechanical mixer such as a ball mill.
  • the time of mixing varies only with the efficiency thereof, as the combination of the polyvinyl pyrrolidone with iodine on its surface is rapid, in fact, such combination will occur to some extent on dropping iodine crystals on the dry powdered polymer.
  • the amount of iodine present as iodide ion is determined by reducing the iodine compound in solution with l-N sodium acid sulfite, adding enough to make the solution colorless, then adding 0.1-N silver nitrate and enough nitric acid to make the solution acidic and back-titrating with ammonium thiocyanate.
  • the iodide ion is the difierence between this figure and the available iodine as determined above.
  • the total iodine may be determined by combustion methods such as that formulated by Hallett in Scotts Standard Method of Chemical Analysis, bound iodine then being determined by subtracting the sum of available iodine and iodide ion from the total iodine as determined above.
  • the product thus obtained may have an available iodine content ranging from 845% and an iodide ion content from 0.98 to 5.6%.
  • the iodine present as available iodine and iodide ion may vary somewhat. On standing, the amount of available iodine slightly decreases while the amount of iodide ion increases. in order to obtain a stable product, Hans Beller et al. referred to above found that a product in which the ratio of available iodine to iodide ion is substantially 2:1 is readily and rapidly obtained by heating the dry blended material in the order of -490 C. Further details regarding this process may be obtained by reference to their patent, the contents of which are incorporated herein by reference, especially, the various iodine-polyvinyl pyrrolidone compositions as prepared in accordance with their Examples 1 to V1 inclusive.
  • the iodine-polyvinyl pyrrolidone compositions prepared in accordance with the aforestated application form aqueous solutions which contain iodine having a very high germicidal activity.
  • the iodine-polyvinyl pyrrolidone composition in aqueous solution has a high acid reaction near a pH of 2, which in some instances, such as, for intravenous use or application on sensitive tissue necessitates the adjustment of such solution to near neutrality. Solutions so adjusted by alkaline agents, especially sodium bicarbonate have a tendency to lose their available iodine activity quite rapidly because of the shift of the hydrolysis equation to the right under increasingly alkaline conditions.
  • the tendency of the iodine-polyvinyl pyrrolidone composition to lose its available iodine content when prepared in aqueous solution. can be very readily overcome by blending 16 to 20 parts by weight of sodium bicarbonate per parts by weight of the iodine-polyvinyl pyrrolidone composition having an available iodine content from 8 to 15% and an available iodide ion content from 0.98 to 5.6% for a period of time ranging from 6 to 36 hours.
  • the resulting product is stable and will readily dissolve in water to form essentially neutral solutions (having a pH range from 6.6 to 6.9).
  • the iodine-polyvinyl pyrrolidone composition is made in a more available and readily useful form for injections and use on mucous tissue.
  • Example 1 To 100 parts of iodine-polyvinyl pyrrolidone composition (made by dry-blending 83.2 parts of polyvinyl pyrrolidone having a K value of 30 and 16.8 parts of iodine for 24 hours, followed by 24 hours of heating at 93 C.) there were added 10 parts of anhydrous sodium bicarbonate. The mixture was blended for 24 hours in a rotating glass vessel to insure uniformity. The product was made up as a 1% aqueous solution and had a pH of 6.7 to 6.9. In aging the dry product for six weeks at 100 F. no change in pH was observed, and no change in the available iodine and iodide ion content was noted.
  • the resulting blend may be packaged as one stable unit and immediately utilized without further compounding. This expedient saves a considerable amount of money in packaging and shipping.
  • the method of forming an aqueous iodine-polyvinylpyrrolidone composition which is stable with respect to a change in pH and loss in available iodine content which comprises blending anhydrous sodium bicarbonate with dry iodine-polyvinyl-pyrrolidone composition until a uniform mixture is obtained, and dissolving the said mixture in water.

Description

PROCESS OF STABILIZING POLYVINYL PYRROLI- DONE-IODINE COMPOSITIONS William A. Hosmer, Pittsiield, Mass., assignor to General Aniline & Film Corporation, New York, N. Y., a corporation of Delaware No Drawing. Application September 22, 1954 Serial No. 457,777
1 Claim. (Cl. 16770) This invention relates to a process of stabilizing a dry powdered adduct of iodine and polymeric 1-vinyl-2- pyrrolidone (hereinafter referred to as polyvinyl pyrrolidone) whereby a stable composition is obtained which when dissolved in water will not change its pH and maintain a constant available iodine content.
In the copending application of Herman A. Shelanski, Serial No. 135,519, filed December 28, 1949, now abandonded, there is disclosed a novel composition of polyvinyl pyrrolidone and iodine which has been found to be of substantial value for many applications in which advantage is taken of the bactericidal activity of the iodine but in which the irritating, sensitizing, and toxic properties of the iodine are substantially overcome. As disclosed in this application, this novel iodine-polyvinyl pyrrolidone composition may be prepared by adding a solution of iodine, such as Lugols solution or tincture of iodine to an aqueous solution of polyvinyl pyrrolidone followed by dessication in a suitable dryer.
To improve on the method of preparing the foregoing novel iodine-polyvinyl pyrrolidone composition, there is disclosed in the copending application of Hans Beller and W. A. Hosmer, Serial No. 282,458, filed April 15, 1952, now U. S. Patent 2,706,701, a process whereby dry elemental iodine is mixed with dry powdered polyvinyl pyrrolidone. The iodine and powdered polymer is mixed until a homogeneous powder is obtained, the mixing being carried out in materials which are not attacked by iodine so as to avoid the introduction of metal ions into the finished composition. This mixing is effected by grinding the iodine and polyvinyl pyrrolidone in a mortar and pestle or more advantageously in a suitable mechanical mixer such as a ball mill. The time of mixing varies only with the efficiency thereof, as the combination of the polyvinyl pyrrolidone with iodine on its surface is rapid, in fact, such combination will occur to some extent on dropping iodine crystals on the dry powdered polymer.
On completion of the mixing there is obtained a compound in a physical state similar to the polymer alone but which contains varying proportions of available iodine (as distinguished from free iodine), iodide ion, and bound iodine. A distinction between these forms may be made on an analytical basis, available iodine being determined directly by dissolving a sample of the product in water and titrating with 0.1-N sodium thiosulfate solution using starch as an indicator. The amount of iodine present as iodide ion is determined by reducing the iodine compound in solution with l-N sodium acid sulfite, adding enough to make the solution colorless, then adding 0.1-N silver nitrate and enough nitric acid to make the solution acidic and back-titrating with ammonium thiocyanate. The iodide ion is the difierence between this figure and the available iodine as determined above. The total iodine may be determined by combustion methods such as that formulated by Hallett in Scotts Standard Method of Chemical Analysis, bound iodine then being determined by subtracting the sum of available iodine and iodide ion from the total iodine as determined above.
The product thus obtained may have an available iodine content ranging from 845% and an iodide ion content from 0.98 to 5.6%. With any given sample of polyvinyl pyrrolidone, the iodine present as available iodine and iodide ion may vary somewhat. On standing, the amount of available iodine slightly decreases while the amount of iodide ion increases. in order to obtain a stable product, Hans Beller et al. referred to above found that a product in which the ratio of available iodine to iodide ion is substantially 2:1 is readily and rapidly obtained by heating the dry blended material in the order of -490 C. Further details regarding this process may be obtained by reference to their patent, the contents of which are incorporated herein by reference, especially, the various iodine-polyvinyl pyrrolidone compositions as prepared in accordance with their Examples 1 to V1 inclusive.
The iodine-polyvinyl pyrrolidone compositions prepared in accordance with the aforestated application form aqueous solutions which contain iodine having a very high germicidal activity. The iodine-polyvinyl pyrrolidone composition in aqueous solution has a high acid reaction near a pH of 2, which in some instances, such as, for intravenous use or application on sensitive tissue necessitates the adjustment of such solution to near neutrality. Solutions so adjusted by alkaline agents, especially sodium bicarbonate have a tendency to lose their available iodine activity quite rapidly because of the shift of the hydrolysis equation to the right under increasingly alkaline conditions.
When aqueous solutions of iodine-polyvinyl pyrrolidone compositions are prepared and the pH adjusted to neutrality by the addition of sodium bicarbonate, the available iodine content decreases and the available iodide ion increases upon storage within a few weeks, thus posing a serious problem when shipping such solutions to hospitals and physicians. From the time the actual solution is made at the dispensing plant and the time at which it arrives in the hospital or physicians oflice, which may require several weeks, the solution loses potency in the available iodine content.
I have discovered that the tendency of the iodine-polyvinyl pyrrolidone composition to lose its available iodine content when prepared in aqueous solution. can be very readily overcome by blending 16 to 20 parts by weight of sodium bicarbonate per parts by weight of the iodine-polyvinyl pyrrolidone composition having an available iodine content from 8 to 15% and an available iodide ion content from 0.98 to 5.6% for a period of time ranging from 6 to 36 hours. The resulting product is stable and will readily dissolve in water to form essentially neutral solutions (having a pH range from 6.6 to 6.9). By this procedure, the iodine-polyvinyl pyrrolidone composition is made in a more available and readily useful form for injections and use on mucous tissue.
It is indeed wholly surprising and unexpected that the reaction indicated by the above equation has been found not to occur in the solid state when sodium bicarbonate is blended with the iodine-polyvinyl pyrrolidone composition even though moisture may be present either in the sodium bicarbonate or the iodine polyvinyl pyrrolidone composition, or both. More surprising is the fact that the solid mixture of iodine-polyvinyl pyrrolidone composition and sodium bicarbonate has the same stability as the dry iodine-polyvinyl pyrrolidone composition alone.
The following example will serve to illustrate how the stabilized iodinepolyvinyl pyrrolidone composition may be prepared in accordance with the present invention. It is to be understood, however, that this example is merely Example I To 100 parts of iodine-polyvinyl pyrrolidone composition (made by dry-blending 83.2 parts of polyvinyl pyrrolidone having a K value of 30 and 16.8 parts of iodine for 24 hours, followed by 24 hours of heating at 93 C.) there were added 10 parts of anhydrous sodium bicarbonate. The mixture was blended for 24 hours in a rotating glass vessel to insure uniformity. The product was made up as a 1% aqueous solution and had a pH of 6.7 to 6.9. In aging the dry product for six weeks at 100 F. no change in pH was observed, and no change in the available iodine and iodide ion content was noted.
For comparison a 1% aqueous solution of the iodinepolyvinyl pyrrolidone composition utilized above, i. e. prior to blending with sodium bicarbonate (having a pH of 2) and adjusted by the addition of anhydrous sodium bicarbonate to a pH of 6.6 to 6.7, the amount of bicarbonate added was not calculated, but made with vigorous stirring with the pH metered electrodes immersed in the solution. In aging this solution at 100 F. for six weeks, the pH increased from 6.6 to 7.4 and the available iodine content decreased from 11.84 to 11.3%, and the iodide content increased from 3.9 to 4.51%.
By blending sodium bicarbonate with the iodine-polyvinyl pyrrolidone composition, the resulting blend may be packaged as one stable unit and immediately utilized without further compounding. This expedient saves a considerable amount of money in packaging and shipping.
I claim:
The method of forming an aqueous iodine-polyvinylpyrrolidone composition which is stable with respect to a change in pH and loss in available iodine content, which comprises blending anhydrous sodium bicarbonate with dry iodine-polyvinyl-pyrrolidone composition until a uniform mixture is obtained, and dissolving the said mixture in water.
References Cited in the file of this patent UNITED STATES PATENTS OTHER REFERENCES Chemical Week, 69:25, Dec. 22, 1951, p. 19.
C and E N (Chem. and Eng. News), Feb. 19, 1951,
p. 664, New Iodine Compound.
Ridge et al.: Control of pH in Bleaching, Textile Manufacturer, July 1942, p. 282.
US457777A 1952-04-15 1954-09-22 Process of stabilizing polyvinyl pyrrolidone-iodine compositions Expired - Lifetime US2826532A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US457777A US2826532A (en) 1952-04-15 1954-09-22 Process of stabilizing polyvinyl pyrrolidone-iodine compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US282458A US2706701A (en) 1952-04-15 1952-04-15 Process for the preparation of iodinepolyvinylpyrrolidone by dry mixing
US457777A US2826532A (en) 1952-04-15 1954-09-22 Process of stabilizing polyvinyl pyrrolidone-iodine compositions

Publications (1)

Publication Number Publication Date
US2826532A true US2826532A (en) 1958-03-11

Family

ID=26961460

Family Applications (1)

Application Number Title Priority Date Filing Date
US457777A Expired - Lifetime US2826532A (en) 1952-04-15 1954-09-22 Process of stabilizing polyvinyl pyrrolidone-iodine compositions

Country Status (1)

Country Link
US (1) US2826532A (en)

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028300A (en) * 1960-09-13 1962-04-03 West Laboratories Inc Germicidal compositions and methods for preparing the same
US3620773A (en) * 1969-04-03 1971-11-16 Robert P Gabriel Method for treating harvested nonchlorophylleous produce
US3898326A (en) * 1973-05-14 1975-08-05 West Laboratories Inc Polyvinylpyrrolidone-iodide compositions and polyvinylpyrrolidone-iodide-iodine complexes prepared therefrom
US4094967A (en) * 1976-10-22 1978-06-13 Allor Foundation Iodine-polyvinylpyrrolidone solid product and method of preparation
US4200710A (en) * 1978-04-28 1980-04-29 Basf Aktiengesellschaft Preparation of polyvinylpyrrolidone-iodine
US4235884A (en) * 1978-03-17 1980-11-25 Nicolas Salkin Method for the preparation of stable aqueous solutions of complexes of polyvinylpyrrolidone and of halogens and the solutions obtained thereby
US4320114A (en) * 1975-09-10 1982-03-16 Basf Aktiengesellschaft Manufacture of aqueous polyvinylpyrrolidone-iodine solutions
US4401651A (en) * 1979-04-18 1983-08-30 Knutson Richard A Wound-healing compositions containing povidone-iodine
US4402937A (en) * 1979-10-18 1983-09-06 Basf Aktiengesellschaft Preparation of PVP-iodine
US4408001A (en) * 1981-04-06 1983-10-04 The Dow Chemical Company Degeneration inhibited sanitizing complexes
US4481167A (en) * 1980-04-11 1984-11-06 The Dow Chemical Company Sanitizing complexes of polyoxazolines or polyoxazines and polyhalide anions
US4844898A (en) * 1986-09-02 1989-07-04 Kowa Co., Ltd. Wound-healing preparations
US5709851A (en) * 1990-03-21 1998-01-20 Euro-Celtique, S.A. Pharmaceutical iodine compositions with reduced irritancy
US5753699A (en) * 1997-01-10 1998-05-19 Medlogic Global Corporation Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent
WO1999020107A1 (en) * 1997-10-21 1999-04-29 West Agro, Inc. Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
US6090397A (en) * 1997-11-03 2000-07-18 Medlogic Global Corporation Kits containing cyanoacrylate compositions comprising an antimicrobial agent
US6475502B1 (en) 1997-11-03 2002-11-05 Flowers Park Ltd. Kits containing cyanoacrylate compositions comprising an antimicrobial agent
US20040074847A1 (en) * 2002-10-16 2004-04-22 Jaquess Percy A. Stable N-bromo-2-pyrrolidone and methods to make the same
US6811771B1 (en) 1999-04-27 2004-11-02 Ebara Corporation Bactericidal organic polymeric material
US20040230309A1 (en) * 2003-02-14 2004-11-18 Depuy Spine, Inc. In-situ formed intervertebral fusion device and method
US6852233B1 (en) 1999-04-27 2005-02-08 Ebara Corporation Metal-collecting apparatus and method for elution and recovery of metal from metal-collecting material
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
CN102093279A (en) * 2011-01-07 2011-06-15 上海宇昂化工科技发展有限公司 High-stability nonionic N-vinyl butyrate lactam iodine and preparation method thereof
WO2012003326A1 (en) 2010-07-02 2012-01-05 Wright Medical Technology, Inc. Composition comprising calcium phosphate and sulfate powders and tri - calcium phosphate particles used in the treatment of degenerative bone conditions
WO2015089373A1 (en) 2013-12-13 2015-06-18 Wright Medical Technology, Inc. Multiphasic bone graft substitute material
US9320614B2 (en) 2006-07-31 2016-04-26 DePuy Synthes Products, Inc. Spinal fusion implant
US9801725B2 (en) 2009-12-09 2017-10-31 DePuy Synthes Products, Inc. Aspirating implants and method of bony regeneration
WO2019046844A1 (en) 2017-09-02 2019-03-07 Iview Therapeutics, Inc. In situ gel-forming pharmaceutical compositions and uses thereof for sinus diseases
US10238500B2 (en) 2002-06-27 2019-03-26 DePuy Synthes Products, Inc. Intervertebral disc
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US10966840B2 (en) 2010-06-24 2021-04-06 DePuy Synthes Products, Inc. Enhanced cage insertion assembly
US10973652B2 (en) 2007-06-26 2021-04-13 DePuy Synthes Products, Inc. Highly lordosed fusion cage
WO2021155165A1 (en) 2020-01-31 2021-08-05 Wright Medical Technology, Inc. Improved bone graft substitute formulation
US11273050B2 (en) 2006-12-07 2022-03-15 DePuy Synthes Products, Inc. Intervertebral implant
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US11446155B2 (en) 2017-05-08 2022-09-20 Medos International Sarl Expandable cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11452607B2 (en) 2010-10-11 2022-09-27 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US11497619B2 (en) 2013-03-07 2022-11-15 DePuy Synthes Products, Inc. Intervertebral implant
US11510788B2 (en) 2016-06-28 2022-11-29 Eit Emerging Implant Technologies Gmbh Expandable, angularly adjustable intervertebral cages
US11596523B2 (en) 2016-06-28 2023-03-07 Eit Emerging Implant Technologies Gmbh Expandable and angularly adjustable articulating intervertebral cages
US11602438B2 (en) 2008-04-05 2023-03-14 DePuy Synthes Products, Inc. Expandable intervertebral implant
US11607321B2 (en) 2009-12-10 2023-03-21 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US11612491B2 (en) 2009-03-30 2023-03-28 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US11612493B2 (en) 2003-06-30 2023-03-28 DePuy Synthes Products, Inc. Intervertebral implant with conformable endplate
US11654033B2 (en) 2010-06-29 2023-05-23 DePuy Synthes Products, Inc. Distractible intervertebral implant
US11737881B2 (en) 2008-01-17 2023-08-29 DePuy Synthes Products, Inc. Expandable intervertebral implant and associated method of manufacturing the same
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11911287B2 (en) 2010-06-24 2024-02-27 DePuy Synthes Products, Inc. Lateral spondylolisthesis reduction cage

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1557266A (en) * 1922-12-27 1925-10-13 Us Ind Alcohol Co Composition adapted to generate free iodine
US1841694A (en) * 1930-05-16 1932-01-19 Eimer & Amend Therapeutic iodine solution
US2386252A (en) * 1942-02-21 1945-10-09 Mendelsohn Majer Antiseptic composition
US2706701A (en) * 1952-04-15 1955-04-19 Gen Aniline & Film Corp Process for the preparation of iodinepolyvinylpyrrolidone by dry mixing

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1557266A (en) * 1922-12-27 1925-10-13 Us Ind Alcohol Co Composition adapted to generate free iodine
US1841694A (en) * 1930-05-16 1932-01-19 Eimer & Amend Therapeutic iodine solution
US2386252A (en) * 1942-02-21 1945-10-09 Mendelsohn Majer Antiseptic composition
US2706701A (en) * 1952-04-15 1955-04-19 Gen Aniline & Film Corp Process for the preparation of iodinepolyvinylpyrrolidone by dry mixing

Cited By (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028300A (en) * 1960-09-13 1962-04-03 West Laboratories Inc Germicidal compositions and methods for preparing the same
US3620773A (en) * 1969-04-03 1971-11-16 Robert P Gabriel Method for treating harvested nonchlorophylleous produce
US3898326A (en) * 1973-05-14 1975-08-05 West Laboratories Inc Polyvinylpyrrolidone-iodide compositions and polyvinylpyrrolidone-iodide-iodine complexes prepared therefrom
US4320114A (en) * 1975-09-10 1982-03-16 Basf Aktiengesellschaft Manufacture of aqueous polyvinylpyrrolidone-iodine solutions
US4094967A (en) * 1976-10-22 1978-06-13 Allor Foundation Iodine-polyvinylpyrrolidone solid product and method of preparation
US4235884A (en) * 1978-03-17 1980-11-25 Nicolas Salkin Method for the preparation of stable aqueous solutions of complexes of polyvinylpyrrolidone and of halogens and the solutions obtained thereby
US4200710A (en) * 1978-04-28 1980-04-29 Basf Aktiengesellschaft Preparation of polyvinylpyrrolidone-iodine
US4401651A (en) * 1979-04-18 1983-08-30 Knutson Richard A Wound-healing compositions containing povidone-iodine
US4402937A (en) * 1979-10-18 1983-09-06 Basf Aktiengesellschaft Preparation of PVP-iodine
US4481167A (en) * 1980-04-11 1984-11-06 The Dow Chemical Company Sanitizing complexes of polyoxazolines or polyoxazines and polyhalide anions
US4408001A (en) * 1981-04-06 1983-10-04 The Dow Chemical Company Degeneration inhibited sanitizing complexes
US4844898A (en) * 1986-09-02 1989-07-04 Kowa Co., Ltd. Wound-healing preparations
US5709851A (en) * 1990-03-21 1998-01-20 Euro-Celtique, S.A. Pharmaceutical iodine compositions with reduced irritancy
US5753699A (en) * 1997-01-10 1998-05-19 Medlogic Global Corporation Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent
WO1999020107A1 (en) * 1997-10-21 1999-04-29 West Agro, Inc. Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
US5916581A (en) * 1997-10-21 1999-06-29 West Agro, Inc. Iodine antimicrobial compositions containing nonionic surfactants and halogen anions
US6090397A (en) * 1997-11-03 2000-07-18 Medlogic Global Corporation Kits containing cyanoacrylate compositions comprising an antimicrobial agent
US6475502B1 (en) 1997-11-03 2002-11-05 Flowers Park Ltd. Kits containing cyanoacrylate compositions comprising an antimicrobial agent
US6811771B1 (en) 1999-04-27 2004-11-02 Ebara Corporation Bactericidal organic polymeric material
US6852233B1 (en) 1999-04-27 2005-02-08 Ebara Corporation Metal-collecting apparatus and method for elution and recovery of metal from metal-collecting material
US10238500B2 (en) 2002-06-27 2019-03-26 DePuy Synthes Products, Inc. Intervertebral disc
US20040074847A1 (en) * 2002-10-16 2004-04-22 Jaquess Percy A. Stable N-bromo-2-pyrrolidone and methods to make the same
US9814589B2 (en) 2003-02-14 2017-11-14 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10433971B2 (en) 2003-02-14 2019-10-08 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US11432938B2 (en) 2003-02-14 2022-09-06 DePuy Synthes Products, Inc. In-situ intervertebral fusion device and method
US11207187B2 (en) 2003-02-14 2021-12-28 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US11096794B2 (en) 2003-02-14 2021-08-24 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10786361B2 (en) 2003-02-14 2020-09-29 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10639164B2 (en) 2003-02-14 2020-05-05 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9333091B2 (en) 2003-02-14 2016-05-10 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10583013B2 (en) 2003-02-14 2020-03-10 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9439776B2 (en) 2003-02-14 2016-09-13 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9439777B2 (en) 2003-02-14 2016-09-13 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10575959B2 (en) 2003-02-14 2020-03-03 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9724207B2 (en) 2003-02-14 2017-08-08 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9730803B2 (en) 2003-02-14 2017-08-15 DePuy Synthes Products, Inc. Method of in-situ formation of an intervertebral fusion device
US10555817B2 (en) 2003-02-14 2020-02-11 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9788963B2 (en) 2003-02-14 2017-10-17 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9801729B2 (en) 2003-02-14 2017-10-31 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10492918B2 (en) 2003-02-14 2019-12-03 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9808351B2 (en) 2003-02-14 2017-11-07 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10420651B2 (en) 2003-02-14 2019-09-24 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9814590B2 (en) 2003-02-14 2017-11-14 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10405986B2 (en) 2003-02-14 2019-09-10 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US9925060B2 (en) 2003-02-14 2018-03-27 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10376372B2 (en) 2003-02-14 2019-08-13 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US10085843B2 (en) 2003-02-14 2018-10-02 DePuy Synthes Products, Inc. In-situ formed intervertebral fusion device and method
US20040230309A1 (en) * 2003-02-14 2004-11-18 Depuy Spine, Inc. In-situ formed intervertebral fusion device and method
US11612493B2 (en) 2003-06-30 2023-03-28 DePuy Synthes Products, Inc. Intervertebral implant with conformable endplate
US9737413B2 (en) 2006-07-31 2017-08-22 DePuy Synthes Products, Inc. Spinal fusion implant
US10010428B2 (en) 2006-07-31 2018-07-03 DePuy Synthes Products, Inc. Spinal fusion implant
US10695191B2 (en) 2006-07-31 2020-06-30 DePuy Synthes Products, Inc. Spinal fusion implant
US9320614B2 (en) 2006-07-31 2016-04-26 DePuy Synthes Products, Inc. Spinal fusion implant
US9387091B2 (en) 2006-07-31 2016-07-12 DePuy Synthes Products, Inc. Spinal fusion implant
US9713538B2 (en) 2006-07-31 2017-07-25 DePuy Synthes Products, Inc. Spinal fusion implant
US11497618B2 (en) 2006-12-07 2022-11-15 DePuy Synthes Products, Inc. Intervertebral implant
US11660206B2 (en) 2006-12-07 2023-05-30 DePuy Synthes Products, Inc. Intervertebral implant
US11432942B2 (en) 2006-12-07 2022-09-06 DePuy Synthes Products, Inc. Intervertebral implant
US11642229B2 (en) 2006-12-07 2023-05-09 DePuy Synthes Products, Inc. Intervertebral implant
US11273050B2 (en) 2006-12-07 2022-03-15 DePuy Synthes Products, Inc. Intervertebral implant
US11712345B2 (en) 2006-12-07 2023-08-01 DePuy Synthes Products, Inc. Intervertebral implant
US20080172032A1 (en) * 2007-01-11 2008-07-17 James Pitzer Gills Method for preventing tissue damage associated with irrigation of tissue with an antimicrobial solution
US10973652B2 (en) 2007-06-26 2021-04-13 DePuy Synthes Products, Inc. Highly lordosed fusion cage
US11622868B2 (en) 2007-06-26 2023-04-11 DePuy Synthes Products, Inc. Highly lordosed fusion cage
US11737881B2 (en) 2008-01-17 2023-08-29 DePuy Synthes Products, Inc. Expandable intervertebral implant and associated method of manufacturing the same
US11712341B2 (en) 2008-04-05 2023-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant
US11707359B2 (en) 2008-04-05 2023-07-25 DePuy Synthes Products, Inc. Expandable intervertebral implant
US11602438B2 (en) 2008-04-05 2023-03-14 DePuy Synthes Products, Inc. Expandable intervertebral implant
US11712342B2 (en) 2008-04-05 2023-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant
US11701234B2 (en) 2008-04-05 2023-07-18 DePuy Synthes Products, Inc. Expandable intervertebral implant
US11617655B2 (en) 2008-04-05 2023-04-04 DePuy Synthes Products, Inc. Expandable intervertebral implant
US11612491B2 (en) 2009-03-30 2023-03-28 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US10342662B2 (en) 2009-12-09 2019-07-09 DePuy Synthes Products, Inc. Aspirating implants and method of bony regeneration
US9801725B2 (en) 2009-12-09 2017-10-31 DePuy Synthes Products, Inc. Aspirating implants and method of bony regeneration
US11607321B2 (en) 2009-12-10 2023-03-21 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US11911287B2 (en) 2010-06-24 2024-02-27 DePuy Synthes Products, Inc. Lateral spondylolisthesis reduction cage
US10966840B2 (en) 2010-06-24 2021-04-06 DePuy Synthes Products, Inc. Enhanced cage insertion assembly
US11872139B2 (en) 2010-06-24 2024-01-16 DePuy Synthes Products, Inc. Enhanced cage insertion assembly
US11654033B2 (en) 2010-06-29 2023-05-23 DePuy Synthes Products, Inc. Distractible intervertebral implant
WO2012003326A1 (en) 2010-07-02 2012-01-05 Wright Medical Technology, Inc. Composition comprising calcium phosphate and sulfate powders and tri - calcium phosphate particles used in the treatment of degenerative bone conditions
EP4186534A1 (en) 2010-07-02 2023-05-31 Agnovos Healthcare, LLC Methods of treating degenerative bone conditions
EP2987507A1 (en) 2010-07-02 2016-02-24 Agnovos Healthcare, LLC Methods of treating degenerative bone conditions
US11452607B2 (en) 2010-10-11 2022-09-27 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
CN102093279B (en) * 2011-01-07 2012-05-23 上海宇昂化工科技发展有限公司 High-stability nonionic N-vinyl butyrate lactam iodine and preparation method thereof
CN102093279A (en) * 2011-01-07 2011-06-15 上海宇昂化工科技发展有限公司 High-stability nonionic N-vinyl butyrate lactam iodine and preparation method thereof
US11497619B2 (en) 2013-03-07 2022-11-15 DePuy Synthes Products, Inc. Intervertebral implant
US11850164B2 (en) 2013-03-07 2023-12-26 DePuy Synthes Products, Inc. Intervertebral implant
EP3269399A1 (en) 2013-12-13 2018-01-17 Agnovos Healthcare, LLC Multiphasic bone graft substitute material
WO2015089373A1 (en) 2013-12-13 2015-06-18 Wright Medical Technology, Inc. Multiphasic bone graft substitute material
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US11596523B2 (en) 2016-06-28 2023-03-07 Eit Emerging Implant Technologies Gmbh Expandable and angularly adjustable articulating intervertebral cages
US11510788B2 (en) 2016-06-28 2022-11-29 Eit Emerging Implant Technologies Gmbh Expandable, angularly adjustable intervertebral cages
US11596522B2 (en) 2016-06-28 2023-03-07 Eit Emerging Implant Technologies Gmbh Expandable and angularly adjustable intervertebral cages with articulating joint
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US11446155B2 (en) 2017-05-08 2022-09-20 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
WO2019046844A1 (en) 2017-09-02 2019-03-07 Iview Therapeutics, Inc. In situ gel-forming pharmaceutical compositions and uses thereof for sinus diseases
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
WO2021155165A1 (en) 2020-01-31 2021-08-05 Wright Medical Technology, Inc. Improved bone graft substitute formulation
US11806245B2 (en) 2020-03-06 2023-11-07 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage

Similar Documents

Publication Publication Date Title
US2826532A (en) Process of stabilizing polyvinyl pyrrolidone-iodine compositions
US2706701A (en) Process for the preparation of iodinepolyvinylpyrrolidone by dry mixing
US2900305A (en) Preparation of iodine polyvinylpyrrolidone adducts
US4025609A (en) Process for preparing stable sodium percarbonate
EP0203526B1 (en) Compounds in melted block form containing alkaline hydroxide and active chlorine for machine dish-washing, and process for their preparation
WO2000018237A1 (en) Stable glycerin iodine concentrate compositions
CA1084657A (en) Stabilized solutions of sodium dithionite
US2840510A (en) Iodine-surface active carrier germicidal preparations
US3992197A (en) Silver crystals and production thereof
US5558881A (en) Iodophors, production and use thereof
US3656890A (en) Chlorinated trisodium phosphates
US3981713A (en) Urea-zinc oxide composition and process
JPH0788236B2 (en) Glass composition for adding synthetic resin
IE52292B1 (en) Stabilised syccinyl peroxide composition
US2807591A (en) Water-soluble gums of improved water solubility and method of producing same
NO117848B (en)
US3087853A (en) Water soluble compositions consisting essentially of iodine and a water soluble oxygen containing polymer
USRE35795E (en) Method of making flowable alkaline thiosulfate/alkaline sulfite and the product thereof
US2729672A (en) Non-hygroscopic choline salts
US3266985A (en) Production of wood preservatives
US3024161A (en) Stable, dry bordeaux mixture
JPS58113143A (en) Novel compounded material and its use
JP2816754B2 (en) Oxygen donor
CN107601929B (en) High-folding-degree cement and preparation method thereof
US376445A (en) Adhesive paste